Neuroendocrine Tumors of the Appendix
Conditions
Brief summary
The aim of the present project is to evaluate the frequency of distant metastases and clinically relevant relapse and mortality, respectively, of aNEN (Neuroendocrine Neoplasms of the Appendix) measuring 1 - 2 cm. The investigators hypothesize that the mortality rate of aNET (Neuroendocrine Tumors of the Appendix) measuring 1 - 2cm is less than 1%. Furthermore, the investigators hypothesize that regional lymph node metastases of aNET measuring 1 - 2 cm are clinically not relevant and are not associated with reduced survival. The investigators therefore hypothesize that oncological right-sided hemicolectomy has no impact on long-term survival after complete resection of aNET measuring 1 - 2 cm and that the malignant potential quo ad vitam of these tumors is lower than the risk of oncological hemicolectomy.
Interventions
Histopathological review
Sponsors
Study design
Eligibility
Inclusion criteria
* The investigators will include all patients with aNET measuring 1 - 2 cm and complete resection between 01.01.2005 and 31.12.2010 of the primary tumor.
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinically relevant relapse of aNET measuring 1 - 2 cm in a population based manner | 10 years |
| Clinically relevant mortality of aNET measuring 1 - 2 cm in a population based manner | 10 years |
| Frequency of distant metastases in aNET measuring 1-2 cm | 10 years |
Secondary
| Measure | Time frame |
|---|---|
| Association of histological risk factors in aNET measuring 1 - 2 cm and qualifying for oncological right-sided hemicolectomy according to ENETS guidelines with the occurrence of regional lymph node and distant metastases | 10 years |
| Relationship between regional lymph node metastasis and survival in patients with aNET measuring 1 - 2 cm | 10 years |
| Long-term survival after complete resection of aNET measuring 1 - 2 cm with or without oncological right-sided hemicolectomy | 10 years |
Countries
Switzerland